Danh Thanh Huynh, PHARM D | |
H100 Santa Margarita Rd, Attention: Code 094 Naval Hospital, Camp Pendleton, Camp Pendleton, CA 92055-5191 | |
(760) 725-8882 | |
(760) 725-1267 |
Full Name | Danh Thanh Huynh |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | H100 Santa Margarita Rd, Camp Pendleton, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033357090 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 53401 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Danh Thanh Huynh, PHARM D H100 Santa Margarita Rd, Attention: Code 094 Naval Hospital, Camp Pendleton, Camp Pendleton, CA 92055-5191 Ph: (760) 725-8882 | Danh Thanh Huynh, PHARM D H100 Santa Margarita Rd, Attention: Code 094 Naval Hospital, Camp Pendleton, Camp Pendleton, CA 92055-5191 Ph: (760) 725-8882 |
News Archive
A new study provides important evidence that the use of certain potentially inappropriate medications (PIMs) among the elderly may increase adverse events and health care costs.
MossRehab (part of the Albert Einstein Healthcare Network) has opened a new Right Hemisphere Stroke Center ― the only center in the nation devoted to managing the unique needs of patients with right hemisphere stroke syndrome.
New results in animals highlight a major safety concern regarding a class of magnetic resonance imaging (MRI) contrast agents used in millions of patients each year, according to a paper published online by the journal Investigative Radiology.
OncoSec Medical Incorporated, which is developing its advanced-stage OMS ElectroOncology therapies for the treatment of solid tumor cancers, announced today the submission of its Device Master File (DMF) to the U.S. Food and Drug Administration (FDA) for its patented OncoSec Medical System (OMS) which consists of a generator and hand-held applicator.
Spectrum Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Prior Approval Supplement containing data providing for the removal of the Indium-111 ZEVALIN® (ibritumomab tiuxetan) pre-treatment imaging evaluation, more commonly referred to as the "bioscan" requirement.
› Verified 8 days ago
Dr. Anand B Valathur, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Brmcl San Onofre 52 Area, Camp Pendleton, CA 92055 Phone: 760-763-2421 | |
Dr. Kara L Jablonski, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: H100 Santa Margarita Road, Attention: Code 00qm, Naval Hospital Camp Pendleton, Camp Pendleton, CA 92055 Phone: 760-725-1477 | |
Dr. Leeza Rahimi, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Santa Margarita Rd, Building H100, Camp Pendleton, CA 92055 Phone: 760-725-8882 | |
Mr. Edward Clifford Norton Jr., R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Naval Hospital, Camp Pendleton, Box 555191 Bldg H100, Camp Pendleton, CA 92055 Phone: 760-725-1147 | |
Dr. Anne Vu Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: H100 Santa Margarita Road, Naval Hospital Camp Pendleton, Camp Pendleton, CA 92055 Phone: 760-725-1489 | |
Bony M Kari, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Naval Hospital, Camp Pendleton-pharmacy Dept, Camp Pendleton, CA 92055 Phone: 760-725-3278 Fax: 760-725-1303 |